1. Home
  2. TRS vs BHVN Comparison

TRS vs BHVN Comparison

Compare TRS & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriMas Corporation

TRS

TriMas Corporation

HOLD

Current Price

$35.04

Market Cap

1.4B

Sector

Industrials

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$9.58

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRS
BHVN
Founded
1986
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
2004
2022

Fundamental Metrics

Financial Performance
Metric
TRS
BHVN
Price
$35.04
$9.58
Analyst Decision
Strong Buy
Buy
Analyst Count
2
14
Target Price
$41.50
$28.85
AVG Volume (30 Days)
464.1K
1.8M
Earning Date
01-01-0001
06-08-2026
Dividend Yield
0.45%
N/A
EPS Growth
400.00
26.08
EPS
2.95
N/A
Revenue
$645,720,000.00
N/A
Revenue This Year
$4.10
N/A
Revenue Next Year
$5.59
N/A
P/E Ratio
$11.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.45
$7.48
52 Week High
$42.00
$31.18

Technical Indicators

Market Signals
Indicator
TRS
BHVN
Relative Strength Index (RSI) 40.98 35.09
Support Level $34.16 $9.32
Resistance Level $37.10 $10.28
Average True Range (ATR) 1.80 0.72
MACD -0.39 -0.13
Stochastic Oscillator 3.57 1.57

Price Performance

Historical Comparison
TRS
BHVN

About TRS TriMas Corporation

TriMas Corp designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense, and industrial markets . The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: